LYEL – lyell immunopharma, inc. (US:NASDAQ)
Stock Stats
News
Keros Therapeutics Appoints Charles Newton to its Board of Directors [Yahoo! Finance]
Lyell Immunopharma Announces Participation in March Investor Conferences
Lyell Immunopharma Announces Initiation of Patient Dosing in First-of-Its-Kind Phase 3 Head-To-Head CAR T-Cell Clinical Trial in Aggressive Large B-Cell Lymphoma
Lyell Immunopharma: LYL314 Drives Momentum Amid Strong ASH Data [Seeking Alpha]
Institutional investors are Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) biggest bettors and were rewarded after last week's US$72m market cap gain [Yahoo! Finance]
Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Seely Lynn
Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Hill Stephen J.
Form 4 Lyell Immunopharma, Inc. For: Feb 11 Filed by: Lee Gary K.
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Hill Stephen J.
Form 4 Lyell Immunopharma, Inc. For: Feb 09 Filed by: Lee Gary K.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.